Undervalued Large-Cap Healthcare Stocks on NYS April 2024

April 05, 2024

Healthcare Sector

The healthcare sector includes companies in biotechnology, pharmaceuticals, hospitals, home and long-term care. It also includes related medical equipment manufacturers and suppliers.

New York Stock Exchange

The New York Stock Exchange, located in New York City, is the largest securities exchange in the world by market capitalization of its listed companies.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Healthcare stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
TDOC Teladoc Health 14.25 44.69 213.61 3924078 2345 0.00 0.0
NVST Envista Holdings 20.48 42.24 106.26 2323706 3418 0.00 0.0
OSCR Oscar Health 13.98 27.40 96.00 2532486 3099 0.00 0.0
TEVA Teva Pharmaceutical Indus 13.93 25.72 84.67 7875702 15588 0.00 0.0
OGN Organon 17.87 32.32 80.86 2019411 4580 6.27 4.5
GMED Globus Medical 51.22 87.11 70.07 1096265 5871 0.00 47.9
PRGO Perrigo 31.45 53.41 69.82 2034140 4255 3.48 0.0
PHG Koninklijke Philips 20.36 33.07 62.41 817448 19514 0.00 0.0
BIO Bio-Rad Laboratories 322.83 523.70 62.22 168590 9430 0.00 0.0
BIO.B Bio-Rad Laboratories 332.20 520.87 56.80 - 9703 0.00 0.0
All data provided as at market close April 03, 2024.

Company Details

Teladoc Health

TDOC:NYS

Close Price

14.25

Our Valuation

44.69

% Difference

213.61

Market Cap ($M)

2345

P/E Ratio

0.0

Teladoc Health is a virtual health provider with a telehealth platform delivering on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue generated from access fees on a subscription basis (per member, per month).

Access the stockcalc valuation


Envista Holdings

NVST:NYS

Close Price

20.48

Our Valuation

42.24

% Difference

106.26

Market Cap ($M)

3418

P/E Ratio

0.0

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables.

Access the stockcalc valuation


Oscar Health

OSCR:NYS

Close Price

13.98

Our Valuation

27.40

% Difference

96.00

Market Cap ($M)

3099

P/E Ratio

0.0

Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.

Access the stockcalc valuation


Teva Pharmaceutical Indus

TEVA:NYS

Close Price

13.93

Our Valuation

25.72

% Difference

84.67

Market Cap ($M)

15588

P/E Ratio

0.0

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the U.S. It also has a significant presence in Europe, Japan, Russia, and Israel.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Organon

OGN:NYS

Close Price

17.87

Our Valuation

32.32

% Difference

80.86

Market Cap ($M)

4580

P/E Ratio

4.5

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan.

Access the stockcalc valuation


Globus Medical

GMED:NYS

Close Price

51.22

Our Valuation

87.11

% Difference

70.07

Market Cap ($M)

5871

P/E Ratio

47.9

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities.

Access the stockcalc valuation


Perrigo

PRGO:NYS

Close Price

31.45

Our Valuation

53.41

% Difference

69.82

Market Cap ($M)

4255

P/E Ratio

0.0

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS.

Access the stockcalc valuation


Koninklijke Philips

PHG:NYS

Close Price

20.36

Our Valuation

33.07

% Difference

62.41

Market Cap ($M)

19514

P/E Ratio

0.0

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Around 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics.

Access the stockcalc valuation


Bio-Rad Laboratories

BIO:NYS

Close Price

322.83

Our Valuation

523.70

% Difference

62.22

Market Cap ($M)

9430

P/E Ratio

0.0

Bio-Rad Laboratories Inc manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. It operates in two industry segments; In Clinical Diagnostics segment, the company manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In Life Sciences segment, the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing.

Access the stockcalc valuation


Bio-Rad Laboratories

BIO.B:NYS

Close Price

332.20

Our Valuation

520.87

% Difference

56.80

Market Cap ($M)

9703

P/E Ratio

0.0

Bio-Rad Laboratories Inc manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. It operates in two industry segments; In Clinical Diagnostics segment, the company manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In Life Sciences segment, the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Teladoc Health and Envista Holdings are the most undervalued Large-Cap Healthcare stocks on the NYS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-april-2024
Teladoc Health $TDOC and Envista Holdings $NVST are the most undervalued Healthcare stocks on the #NYS. See the full list: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-april-2024
Teladoc Health and Envista Holdings are the most undervalued Large-Cap Healthcare stocks on the NYS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-april-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.